All GP articles
-
PHE/DH/DWP guidelinePHE management of patient/staff exposure to COVID-19
This summary provides guidance on the management of staff and patients according to exposures, symptoms, and test results
-
Guidance card
NICE Technology Appraisal 664: Liraglutide for managing overweight and obesity
The production and printing of this Guidelines summary card has been commissioned by Novo Nordisk Ltd. Information intended for UK healthcare professionals only.
View prescribing information
UK20SX00231
December 2020 -
News
PHE launches nationwide Every Mind Matters campaign
Following a survey that revealed the impact COVID-19 has had on adults’ mental wellbeing across the country, Public Health England has launched a new campaign to support mental health
-
PHE/DH/DWP guideline
NHS England COVID-19 vaccination SOP
This standard operating procedure (SOP) summary describes the operating model and design requirements for safe delivery of COVID-19 vaccines in the community
-
Information
Key COVID-19 guidance for primary care
The Guidelines team has produced the following directory of COVID-19 information and guidance for primary care. Included on this page is a collection of key guidance and advice from PHE and the NHS, as well as a list of information for specific groups from a range of professional bodies.
-
News
UK government publishes largest ever vaccination delivery plan
The British government has set out a plan that aims to vaccinate millions of people against COVID-19 by the spring
-
News
New strategy to improve diagnosis and treatment of rare diseases
The new Rare Diseases Framework will raise awareness of rare diseases, speed up diagnosis, and improve care and treatment
-
PHE/DH/DWP guideline
PHE COVID-19 vaccination guidance
A concise summary of guidance for healthcare professionals about the COVID-19 vaccination programme
-
News
JCVI advises up to 12-week COVID-19 vaccine dose interval
The JCVI has published a statement on increasing the short-term impact of the vaccination programme, following identification of a new variant of COVID-19 in the UK
-
News
Moderna COVID-19 vaccine approved by MHRA
The Moderna vaccine has become the third COVID-19 vaccine—and the second mRNA COVID-19 vaccine—to be approved for use in the UK
-
NICE guideline
NICE pancreatitis guideline
Summary of NICE guidance on pancreatitis covers managing complications, nutrition support, and referral for specialist treatment
-
News
First Oxford AstraZeneca COVID-19 vaccinations administered
The NHS has begun administering the new Oxford AstraZeneca coronavirus vaccine, which was approved last week
-
Hosted content
COPD: LAMA/LABA therapy—Real life case studies
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200015 V2.0 -
Hosted content
COPD: LAMA/LABA as initial maintenance therapy for appropriate symptomatic patients
This promotional resource has been funded and provided by GSK. Information intended for UK healthcare professionals only.
PM-GB-UCV-WCNT-200014 V2.0 -
NICE guideline
NICE heavy menstrual bleeding guideline
Includes updated recommendations on management and investigations on the causes of heavy menstrual bleeding. Also covers history taking, and provision of information
-
NICE guideline
NICE low back pain and sciatica guideline
A practical summary of the updated 2016 NICE guideline on the early management of persistent mechanical non-specific low back pain.
-
PHE/DH/DWP guideline
Reporting of diseases by prison and detention centres guideline
A short summary of Public Health England's list of reportable diseases in prison and detention centres. Includes a simple flowchart to help with reporting.
-
NICE guideline
NICE ‘long COVID’ guideline
Recommendations for identifying and managing ‘long-COVID’ in primary care
-
Video
Non-alcoholic steatohepatitis: identification, management, and referral pathways
The content on this page is intended for UK healthcare professionals only.
-
News
New COVID guidelines focus on long-term effects and vitamin D
New NICE guidelines focus on managing the long-term effects of COVID-19, and vitamin D use in the context of COVID‑19
